Philip J. Larsen

Investigating Intestinal Glucagon after Roux-en-Y Gastric Bypass Surgery.

P. J. Larsen, J. Holst, J. Jelsing, 2019, The Journal of clinical endocrinology and metabolism.

Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.

P. J. Larsen, L. B. Knudsen, C. Fledelius, 2001, Diabetes.

The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex.

P. J. Larsen, P. Kristensen, Philip J. Larsen, 1997, Brain research. Molecular brain research.

Combination of the insulin sensitizer, pioglitazone, and the long‐acting GLP‐1 human analog, liraglutide, exerts potent synergistic glucose‐lowering efficacy in severely diabetic ZDF rats

J. Sturis, N. Vrang, L. B. Knudsen, 2008, Diabetes, obesity & metabolism.

Distribution of neuropeptide Y receptor expression in the rat suprachiasmatic nucleus.

P. J. Larsen, P. Kristensen, Philip J. Larsen, 1998, Brain research. Molecular brain research.